Key Takeaways
- Digitalisation and AI tools are revolutionizing the pharmaceutical industry from research to logistics.
- Major topics at AUTOMA+ 2025 include lab automation, supply chain optimisation, and digital compliance.
- Innovative companies are presenting advanced solutions to enhance efficiency and adaptability in drug development and logistics.
Transforming the Pharmaceutical Landscape
The pharmaceutical sector is witnessing a profound transformation driven by digitalisation and AI-powered technologies. These advancements are enhancing every stage of the pharmaceutical process, from initial research to large-scale production and logistics. The upcoming Pharmaceutical Automation and Digitalisation Congress, AUTOMA+ 2025, scheduled for November 24-25 in Vösendorf, Austria, will spotlight these trends, gathering over 290 industry professionals to discuss the impacts of digital technologies on drug discovery, development, and delivery.
One notable project is by CellVoyant, an AI-focused biotech company aiming to innovate stem cell therapies. Using live cell imaging combined with machine learning, CellVoyant allows for real-time observation and enhancement of stem cell differentiation—a traditionally slow and inefficient process. Elisa Pedone, Senior Research Scientist at CellVoyant, will showcase the FateView platform at the congress, which leverages computer vision for optimal drug development decisions.
Logistics also face significant changes, particularly in response to increasing demands for climate neutrality and transparency amid workforce shortages. The “Shared Logistics Position Paper” from Fraunhofer Austria Research GmbH underscores this shift, proposing the collaborative use of data and resources to foster resilient supply chains. Martin Riester, Director at Fraunhofer, will present examples at AUTOMA+ 2025 that highlight the effectiveness of AI and data science in improving supply chain performance, maintenance, and inventory management.
Furthermore, digital compliance is a key focus, as pharmaceutical companies often struggle with lengthy adaptation processes to meet new market demands. Anic GmbH addresses this with its anicomply application, which facilitates rapid publication of Electronic Batch Record (EBR) recipes. This tool significantly reduces the time needed for adjustments, allowing for immediate compliance while capturing production data for real-time monitoring. Denis Nicklas, the company’s founder, will discuss how their solutions are addressing ongoing challenges in the industry.
The convergence of these digital solutions is not only enhancing individual processes but is also fostering a more interconnected and efficient pharmaceutical ecosystem. AUTOMA+ 2025 serves as a unique platform for experts and decision-makers to explore these innovations and engage in meaningful conversations on how collaboration and digital solutions can shape the future of pharmaceutical development.
As the industry faces an unyielding demand for innovation and efficiency, embracing digitalisation is more critical than ever. The congress will be instrumental in showcasing how these advancements can create a more agile and forward-thinking pharmaceutical landscape, enabling companies to respond effectively to evolving market needs and consumer demands.
The content above is a summary. For more details, see the source article.
